пси洛西宾诱导的神经可塑性的新出现的机制
Sonia Sonda1, Diana Pendin1, Stefano Comai2
1Neuroscience Institute, National Research Council (CNR), Padua, Italy; Department of Biomedical Sciences, University of Padua, Padua, Italy.
Trends in pharmacological sciences
|September 16, 2025
概括
赛洛西宾通过增强神经元可塑性,对抑郁症表现出快速的治疗效果. 它的机制涉及多个血清素受体和除了血清素2A受体之外的其他点,表明了更广泛的应用.
科学领域:
- 神经科学是一个神经科学.
- 药理学 药理学是指药理学的学科.
- 精神病学是一个精神病学.
背景情况:
- 一种迷幻化合物psilocybin因其在治疗抑郁症等神经精神疾病方面的潜力而受到认可.
- 它的治疗效果通常与增强的神经元可塑性有关.
- 目前的理解主要将这些影响归因于血清素2A (5-HT2A) 受体的激活.
研究的目的:
- 审查psilocin的分子相互作用,psilocybin的活性代谢物.
- 为了探索超越5-HT2A受体激动症的细微药理学.
- 为了提供一个精细的框架,以了解psilocybin的作用和开发新的神经细胞原体.
主要方法:
- 文献综述整合了目前关于西洛分子相互作用组的研究结果.
- 强调受体选择性和偏见激进主义.
- 考虑细胞内受体局部化.
主要成果:
- 新出现的证据表明psilocybin与多种类型的血清素受体子类型相互作用.
- 像TrkB这样的非血性标也与 пси洛西宾的作用有关.
- 西洛辛的药理学概况比以前认为的要复杂得多.
结论:
- 西的治疗潜力可能源于更广泛的分子点.
- 了解偏向激素和细胞内局部化是 psilocybin 持续作用的关键.
- 这种精细的理解可以指导开发更具特异性和更安全的神经可塑性增强药物.
相关概念视频
Neuroplasticity
1.6K
Neuroplasticity reflects the brain's remarkable capacity to adapt and evolve, responding dynamically to learning, experiences, or injury by reorganizing its neural circuitry. This reorganization involves creating new neural connections and refining old ones through a series of biological processes that contribute to the brain's lifelong development and adaptability.
1.6K
Long-term Potentiation
3.4K
Long-term potentiation, or LTP, is one of the ways by which synaptic plasticity—changes in the strength of chemical synapses—can occur in the brain. LTP is the process of synaptic strengthening that occurs over time between pre and postsynaptic neuronal connections. The synaptic strengthening of LTP works in opposition to the synaptic weakening of long-term depression (LTD) and together are the main mechanisms that underlie learning and memory.
Hebbian LTP
LTP can occur when...
Hebbian LTP
LTP can occur when...
3.4K
Long-term Potentiation
58.3K
Long-term potentiation, or LTP, is one of the ways by which synaptic plasticity—changes in the strength of chemical synapses—can occur in the brain. LTP is the process of synaptic strengthening that occurs over time between pre- and postsynaptic neuronal connections. The synaptic strengthening of LTP works in opposition to the synaptic weakening of long-term depression (LTD) and together are the main mechanisms that underlie learning and memory.
58.3K
CNS Stimulants: Psychedelic Agents
696
Hallucinogens, also known as psychedelic drugs, are a class of substances known for their ability to alter perception, cognition, and emotions. Despite their profound effects on the mind, these drugs are non-addictive, setting them apart from many other abused substances. The mechanism of action of these drugs lies in their impact on the 5-HT2A receptor in the brain. Upon activation, this receptor couples to Gq-type G proteins, triggering a cascade that releases intracellular calcium. This...
696
Hallucinogens and Psychedelics
616
Hallucinogens are psychoactive substances that profoundly alter perceptual experiences, generating unreal visual and sensory images. Often referred to as psychedelic drugs — a term derived from the Greek words "psyche" (mind) and "delos" (revealing) — these substances include marijuana and lysergic acid diethylamide (LSD), among others. These drugs vary in intensity and effects.
Marijuana, derived from the dried leaves and flowers of the hemp plant, contains...
Marijuana, derived from the dried leaves and flowers of the hemp plant, contains...
616
Psychosis: Pathophysiology of Schizophrenia and Other Psychotic Disorders
1.8K
Schizophrenia is a neurodevelopmental disorder whose origins are rooted in complex genetic components. Despite our burgeoning understanding, the pathophysiology of this disorder remains incompletely deciphered.
Researchers have identified genetic factors that increase susceptibility to schizophrenia, underscoring the intricate interplay between genetics and environment in disease development. At the core of schizophrenia's pathophysiology is excessive dopaminergic neurotransmission within...
Researchers have identified genetic factors that increase susceptibility to schizophrenia, underscoring the intricate interplay between genetics and environment in disease development. At the core of schizophrenia's pathophysiology is excessive dopaminergic neurotransmission within...
1.8K


